Osaka, Japan

Tomoki Koide

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Shimano Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tomoki Koide: Innovator in Bicycle Technology

Introduction

Tomoki Koide is a prominent inventor based in Osaka, Japan. He is known for his innovative contributions to bicycle technology, particularly in enhancing safety and functionality through advanced components. His work reflects a commitment to improving the cycling experience for users around the world.

Latest Patents

Tomoki Koide holds a patent for a bicycle component that integrates a sensor, a controller, and a communicator. The sensor is designed to detect inputs from obstacles, while the controller processes this information to identify unusual states of the bicycle component. The communicator then relays this information to a connected communication device, ensuring that cyclists are informed of potential hazards.

Career Highlights

Throughout his career, Tomoki has made significant strides in the field of bicycle technology. His work at Shimano Inc. has positioned him as a key player in the development of innovative cycling solutions. His dedication to research and development has led to advancements that enhance both safety and performance in cycling.

Collaborations

Tomoki Koide collaborates with talented individuals such as Akihiro Nozaki and Tomohiro Takimoto. Together, they work on various projects that aim to push the boundaries of bicycle technology and improve user experience.

Conclusion

Tomoki Koide's contributions to bicycle technology exemplify the spirit of innovation. His patented inventions and collaborative efforts continue to shape the future of cycling, making it safer and more enjoyable for everyone.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…